Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005929 | cilium | 4 | 12 |
GO:0042995 | cell projection | 2 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 12 |
Related structures:
AlphaFold database: Q4Q8Q3
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009966 | regulation of signal transduction | 4 | 2 |
GO:0009968 | negative regulation of signal transduction | 5 | 2 |
GO:0009987 | cellular process | 1 | 12 |
GO:0010646 | regulation of cell communication | 4 | 2 |
GO:0010648 | negative regulation of cell communication | 5 | 2 |
GO:0016311 | dephosphorylation | 5 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0023051 | regulation of signaling | 3 | 2 |
GO:0023057 | negative regulation of signaling | 4 | 2 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043408 | regulation of MAPK cascade | 6 | 2 |
GO:0043409 | negative regulation of MAPK cascade | 7 | 2 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0048523 | negative regulation of cellular process | 4 | 2 |
GO:0048583 | regulation of response to stimulus | 3 | 2 |
GO:0048585 | negative regulation of response to stimulus | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1902531 | regulation of intracellular signal transduction | 5 | 2 |
GO:1902532 | negative regulation of intracellular signal transduction | 6 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 12 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 4 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0016791 | phosphatase activity | 5 | 12 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 116 | 120 | PF00656 | 0.483 |
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.477 |
CLV_NRD_NRD_1 | 188 | 190 | PF00675 | 0.490 |
CLV_NRD_NRD_1 | 57 | 59 | PF00675 | 0.656 |
CLV_PCSK_KEX2_1 | 188 | 190 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 241 | 243 | PF00082 | 0.356 |
CLV_PCSK_PC1ET2_1 | 241 | 243 | PF00082 | 0.523 |
CLV_PCSK_PC7_1 | 237 | 243 | PF00082 | 0.580 |
CLV_PCSK_SKI1_1 | 242 | 246 | PF00082 | 0.390 |
CLV_PCSK_SKI1_1 | 356 | 360 | PF00082 | 0.367 |
CLV_PCSK_SKI1_1 | 368 | 372 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 381 | 385 | PF00082 | 0.328 |
CLV_Separin_Metazoa | 414 | 418 | PF03568 | 0.526 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 134 | 143 | PF00134 | 0.513 |
DOC_CYCLIN_yCln2_LP_2 | 223 | 229 | PF00134 | 0.460 |
DOC_MAPK_gen_1 | 241 | 247 | PF00069 | 0.435 |
DOC_MAPK_gen_1 | 352 | 360 | PF00069 | 0.365 |
DOC_MAPK_gen_1 | 55 | 65 | PF00069 | 0.622 |
DOC_PP2B_LxvP_1 | 325 | 328 | PF13499 | 0.340 |
DOC_USP7_MATH_1 | 333 | 337 | PF00917 | 0.475 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.665 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.460 |
DOC_USP7_UBL2_3 | 102 | 106 | PF12436 | 0.319 |
DOC_USP7_UBL2_3 | 55 | 59 | PF12436 | 0.725 |
LIG_14-3-3_CanoR_1 | 105 | 110 | PF00244 | 0.274 |
LIG_14-3-3_CanoR_1 | 237 | 245 | PF00244 | 0.492 |
LIG_14-3-3_CanoR_1 | 291 | 297 | PF00244 | 0.379 |
LIG_14-3-3_CanoR_1 | 43 | 49 | PF00244 | 0.650 |
LIG_14-3-3_CanoR_1 | 58 | 65 | PF00244 | 0.527 |
LIG_14-3-3_CanoR_1 | 80 | 84 | PF00244 | 0.538 |
LIG_14-3-3_CanoR_1 | 91 | 99 | PF00244 | 0.521 |
LIG_Actin_WH2_2 | 278 | 293 | PF00022 | 0.328 |
LIG_Actin_WH2_2 | 367 | 383 | PF00022 | 0.475 |
LIG_Actin_WH2_2 | 92 | 107 | PF00022 | 0.467 |
LIG_AP2alpha_1 | 341 | 345 | PF02296 | 0.475 |
LIG_AP2alpha_2 | 181 | 183 | PF02296 | 0.501 |
LIG_APCC_ABBA_1 | 296 | 301 | PF00400 | 0.410 |
LIG_APCC_ABBA_1 | 338 | 343 | PF00400 | 0.437 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.685 |
LIG_BRCT_BRCA1_1 | 164 | 168 | PF00533 | 0.508 |
LIG_BRCT_BRCA1_1 | 27 | 31 | PF00533 | 0.747 |
LIG_BRCT_BRCA1_1 | 44 | 48 | PF00533 | 0.461 |
LIG_FHA_1 | 135 | 141 | PF00498 | 0.456 |
LIG_FHA_1 | 238 | 244 | PF00498 | 0.551 |
LIG_FHA_1 | 293 | 299 | PF00498 | 0.336 |
LIG_FHA_1 | 369 | 375 | PF00498 | 0.367 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.685 |
LIG_FHA_2 | 382 | 388 | PF00498 | 0.364 |
LIG_FHA_2 | 66 | 72 | PF00498 | 0.604 |
LIG_LIR_Gen_1 | 126 | 135 | PF02991 | 0.504 |
LIG_LIR_Gen_1 | 165 | 174 | PF02991 | 0.566 |
LIG_LIR_Gen_1 | 212 | 223 | PF02991 | 0.519 |
LIG_LIR_Gen_1 | 228 | 235 | PF02991 | 0.426 |
LIG_LIR_Gen_1 | 265 | 276 | PF02991 | 0.428 |
LIG_LIR_Gen_1 | 283 | 290 | PF02991 | 0.249 |
LIG_LIR_Gen_1 | 297 | 307 | PF02991 | 0.413 |
LIG_LIR_Gen_1 | 8 | 15 | PF02991 | 0.657 |
LIG_LIR_Nem_3 | 126 | 130 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 165 | 171 | PF02991 | 0.571 |
LIG_LIR_Nem_3 | 228 | 232 | PF02991 | 0.523 |
LIG_LIR_Nem_3 | 265 | 271 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 283 | 287 | PF02991 | 0.227 |
LIG_LIR_Nem_3 | 297 | 302 | PF02991 | 0.269 |
LIG_LIR_Nem_3 | 342 | 348 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.624 |
LIG_LYPXL_L_2 | 276 | 285 | PF13949 | 0.420 |
LIG_Pex14_2 | 341 | 345 | PF04695 | 0.348 |
LIG_PTB_Apo_2 | 121 | 128 | PF02174 | 0.510 |
LIG_SH2_CRK | 229 | 233 | PF00017 | 0.573 |
LIG_SH2_STAP1 | 412 | 416 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.511 |
LIG_SH2_STAT5 | 284 | 287 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 306 | 309 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 376 | 379 | PF00017 | 0.319 |
LIG_SH3_3 | 112 | 118 | PF00018 | 0.536 |
LIG_SH3_3 | 179 | 185 | PF00018 | 0.493 |
LIG_SH3_3 | 314 | 320 | PF00018 | 0.395 |
LIG_Sin3_3 | 388 | 395 | PF02671 | 0.449 |
LIG_SUMO_SIM_anti_2 | 386 | 393 | PF11976 | 0.449 |
LIG_SUMO_SIM_par_1 | 113 | 119 | PF11976 | 0.466 |
LIG_SUMO_SIM_par_1 | 200 | 206 | PF11976 | 0.510 |
LIG_TRAF2_1 | 210 | 213 | PF00917 | 0.469 |
LIG_TRAF2_1 | 411 | 414 | PF00917 | 0.359 |
LIG_TYR_ITIM | 227 | 232 | PF00017 | 0.549 |
LIG_TYR_ITIM | 282 | 287 | PF00017 | 0.493 |
LIG_UBA3_1 | 377 | 381 | PF00899 | 0.449 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.510 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.675 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.317 |
MOD_CK1_1 | 32 | 38 | PF00069 | 0.640 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.563 |
MOD_CK1_1 | 61 | 67 | PF00069 | 0.589 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.384 |
MOD_CK2_1 | 105 | 111 | PF00069 | 0.527 |
MOD_CK2_1 | 200 | 206 | PF00069 | 0.510 |
MOD_CK2_1 | 207 | 213 | PF00069 | 0.397 |
MOD_CK2_1 | 63 | 69 | PF00069 | 0.568 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.512 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.614 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.647 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.396 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.426 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.408 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.708 |
MOD_GSK3_1 | 364 | 371 | PF00069 | 0.326 |
MOD_GSK3_1 | 415 | 422 | PF00069 | 0.619 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.527 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.454 |
MOD_N-GLC_1 | 123 | 128 | PF02516 | 0.557 |
MOD_N-GLC_1 | 159 | 164 | PF02516 | 0.439 |
MOD_N-GLC_1 | 85 | 90 | PF02516 | 0.384 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.540 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.285 |
MOD_NEK2_1 | 286 | 291 | PF00069 | 0.441 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.719 |
MOD_NEK2_1 | 366 | 371 | PF00069 | 0.343 |
MOD_NEK2_1 | 415 | 420 | PF00069 | 0.505 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.466 |
MOD_PIKK_1 | 256 | 262 | PF00454 | 0.303 |
MOD_PKA_1 | 105 | 111 | PF00069 | 0.528 |
MOD_PKA_1 | 58 | 64 | PF00069 | 0.617 |
MOD_PKA_2 | 236 | 242 | PF00069 | 0.546 |
MOD_PKA_2 | 42 | 48 | PF00069 | 0.645 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.554 |
MOD_PKA_2 | 90 | 96 | PF00069 | 0.405 |
MOD_Plk_1 | 159 | 165 | PF00069 | 0.436 |
MOD_Plk_1 | 333 | 339 | PF00069 | 0.475 |
MOD_Plk_1 | 76 | 82 | PF00069 | 0.448 |
MOD_Plk_1 | 85 | 91 | PF00069 | 0.356 |
MOD_Plk_2-3 | 15 | 21 | PF00069 | 0.732 |
MOD_Plk_2-3 | 225 | 231 | PF00069 | 0.525 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.384 |
MOD_Plk_4 | 200 | 206 | PF00069 | 0.510 |
MOD_Plk_4 | 294 | 300 | PF00069 | 0.404 |
MOD_Plk_4 | 333 | 339 | PF00069 | 0.398 |
MOD_SUMO_rev_2 | 108 | 115 | PF00179 | 0.462 |
MOD_SUMO_rev_2 | 9 | 18 | PF00179 | 0.726 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.523 |
TRG_ENDOCYTIC_2 | 284 | 287 | PF00928 | 0.415 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.220 |
TRG_ENDOCYTIC_2 | 412 | 415 | PF00928 | 0.449 |
TRG_ER_diArg_1 | 187 | 189 | PF00400 | 0.518 |
TRG_ER_diArg_1 | 250 | 253 | PF00400 | 0.478 |
TRG_ER_diArg_1 | 416 | 419 | PF00400 | 0.528 |
TRG_Pf-PMV_PEXEL_1 | 346 | 350 | PF00026 | 0.458 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE85 | Leptomonas seymouri | 63% | 100% |
A0A0S4IVI6 | Bodo saltans | 32% | 100% |
A0A1X0NVC7 | Trypanosomatidae | 47% | 100% |
A0A3Q8IEF5 | Leishmania donovani | 96% | 100% |
A0A3R7KS85 | Trypanosoma rangeli | 45% | 100% |
A4HG58 | Leishmania braziliensis | 82% | 100% |
A4I390 | Leishmania infantum | 96% | 100% |
D0A7R6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9AZH8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
V5B7J4 | Trypanosoma cruzi | 48% | 100% |